Gujarat Themis Biosyn Ltd: Reminder for Special Window for Physical Share Transfer
Gujarat Themis Biosyn Limited reminds shareholders about its special window for re-lodging transfer requests for physical shares, open until January 6, 2026. This applies to requests rejected before April 1, 2019. Transfers will be processed in dematerialized form.
This is a standard regulatory compliance communication and a reminder about an existing process. It does not introduce new information that is expected to significantly impact the company's operations or financial standing.
The announcement is a routine procedural update regarding a special window for share transfers and does not contain any financial performance indicators or strategic business developments that would influence the company's stock price significantly.
Gujarat Themis Biosyn Limited has issued a notice to its shareholders regarding a reminder about the special one-time window for the re-lodgement of transfer requests for physical shares. This window, opened pursuant to a SEBI circular dated July 2, 2025, is available until January 6, 2026.
The facility is applicable to transfer requests that were rejected or returned unattended before April 1, 2019, due to deficiencies in documents or process. All re-lodged requests for the transfer of equity shares will be processed in dematerialized form only, subject to successful verification of documents.
Eligible shareholders are encouraged to submit their requests along with the necessary documents to the Company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited, located at C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai – 400083. The company urges investors to take prompt action to regularize any pending transfer cases.
What to do with a filing like this
Gujarat Themis Biosyn Limited filed this with the NSE as a statutory disclosure, categorised under shareholder meetings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Themis Biosyn Limited. Read the original for the full detail.